MAPT and Alzheimer disease: CSF t-tau increased in AD compared to normal control and PSP (P < 0.05) and can differentiate AD from FTLD-tau (PSP, CBD, AGD, PiD, FTLD-MAPT) with an AUC of 0.794 (Supplementary Fig. 3b).